Skip to search formSkip to main contentSkip to account menu

Stage 0 Oropharyngeal Squamous Cell Carcinoma

Known as: Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v7, Oropharynx Epidermoid Carcinoma in situ, Stage 0 Oropharynx Squamous Cell Carcinoma 
Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)
National Institutes of Health

Related topics

Related topics

14 relations
Epithelial CellsEpitheliumHead and neck structureMalignant Epithelial Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.
2018
2018
Plattenepithelkarzinome des Kopf-Hals-Bereichs
ZusammenfassungPlattenepithelkarzinome der Kopf-Hals-Region (HNSCC) sind nach wie vor eine therapeutische Herausforderung. Auch… 
2017
2017
Lugol Chromoscopy in the Follow-up of Head and Neck Carcinoma
Introduction: Lugol is helpful in identifying early second primary tumors (SPTs) during oroscopy and pharyngoscopy, but this… 
2016
2016
P16 Cutoff in Head and Neck Squamous Cell Carcinoma: Correlation between Tumor and Patient Characteristics and Outcome
Background p16 has been indicated as a suitable surrogate biomarker of HPV infection. The prognosis of p16-positive oropharynx… 
Highly Cited
2014
Highly Cited
2014
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.
PURPOSE To report results of a randomized phase II trial (Radiation Therapy Oncology Group RTOG-0234) examining concurrent… 
2010
2010
Survival trends in head and neck cancer: opportunities for improving outcomes.
This editorial discusses the Pulte and Brenner article on the recent survival trend observed in patients with squamous cell… 
2002
2002
Do Ki67, S-phase, S + G2M and DNA ploidy, evaluated by flow cytometry, reveal locoregional metastasis in oral cavity and oropharynx carcinomas?
Tumour cell proliferation is an important biological prognostic parameter to be considered alongside clinical and… 
1998
1998
Concomitant boost radiotherapy in oropharynx carcinomas.
Fifty-five patients with resectable and unresectable oropharynx carcinomas were treated with concomitant boost radiotherapy… 
1990
1990
Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation--5 year results.
Induction chemotherapy (CT) has demonstrated overall response rates of 80% for oropharynx carcinomas, but no overall survival… 
1988
1988
[Advanced carcinoma of the oropharynx: the value of induction chemotherapy before locoregional treatment. A retrospective study of 138 cases].
Induction chemotherapy in oropharynx carcinomas had demonstrated overall response rates of 80%, but no overall survival benefit… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)